Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Becton Dickinson and Co (BDX) – Becton Dickinson and Co Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

BDX trades at $144.18, down 2.26% on the day, with a bearish technical signal from moving averages but recent Q2 2026 earnings beat expectations. Revenue grew to $21.92B in 2025, with a net income margin of 5.12%, while valuation ratios like P/E of 25.16 and P/S of 1.86 suggest moderate pricing. The company raised its annual profit forecast and appointed a new CFO, reflecting operational strength amid broad-based growth across its medical technology portfolio.
The outlook is mixed; analyst consensus leans neutral with a $172.33 price target implying 20% upside, but risks include rising debt levels and competitive pressures. Earnings momentum from recent beats supports potential gains, yet investors face volatility from macroeconomic headwinds and execution challenges in key markets like China.
Read full analysis

Key Stats

  • Market Cap
    $39.81B
  • Sector
    Health
  • 3M Drawdown
    -22.78%
  • Enterprise Value
    $56.27B
  • Dividend Yield
    2.91%
  • Trading Activity
    26% Buy | 74% Sell
  • Typical Hold Time
    90 days
$144.6
52W Low: $132.35
20 Jun 2025
52W High: $185.39
20 Feb 2026

Becton Dickinson and Co (BDX) is currently valued at a market capitalization of $39.81B, with an enterprise value of $56.27B. Over the past 52 weeks, Becton Dickinson and Co has traded between a low of $132.35 and a high of $185.39, highlighting its annual price range. Over the past three months, Becton Dickinson and Co has recorded a drawdown of -22.78%, reflecting recent price volatility. Becton Dickinson and Co offers a dividend yield of 2.91%, with the most recent dividend of $1.05 paid on 10 Mar 26. On average, investors hold Becton Dickinson and Co for approximately 90 days, indicating typical investor behavior on the platform.

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.


Technical Indicators
|
|
|
Overall Summary
Bearish (15)Neutral (10)Bullish (2)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $39.81B
  • Sector
    Health
  • 3M Drawdown
    -22.78%
  • Enterprise Value
    $56.27B
  • Dividend Yield
    2.91%
  • Trading Activity
    26% Buy | 74% Sell
  • Typical Hold Time
    90 days
$144.6
52W Low: $132.35
20 Jun 2025
52W High: $185.39
20 Feb 2026

Becton Dickinson and Co (BDX) is currently valued at a market capitalization of $39.81B, with an enterprise value of $56.27B. Over the past 52 weeks, Becton Dickinson and Co has traded between a low of $132.35 and a high of $185.39, highlighting its annual price range. Over the past three months, Becton Dickinson and Co has recorded a drawdown of -22.78%, reflecting recent price volatility. Becton Dickinson and Co offers a dividend yield of 2.91%, with the most recent dividend of $1.05 paid on 10 Mar 26. On average, investors hold Becton Dickinson and Co for approximately 90 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!